|Articles|November 6, 2009

Medical Economics, Digital Edition, November 6th, 2009

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Latest CME

Video

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Medical Economics, Digital Edition, November 6th, 2009

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Trending on Medical Economics

Physicians have 5 responsibilities that AI will not replace: AMA

What physicians can actually do about a fake or defamatory online review

Primary care cuts the financial and human cost of chronic disease. So why isn’t the nation investing in it?

Kennedy asks the public to weigh in on the AMA's control of codes by Sept. 14

AAFP issues fall vaccine recommendations amid competing guidance